Recently, several companies focused on AI in healthcare announced significant funding rounds. This surge comes just in time for the J.P. Morgan Healthcare conference and suggests a promising year for investments in AI.
Here are some highlights from the recent funding announcements:
- Innovaccer: $245 million for their healthcare data platform, emphasizing AI capabilities.
- Hippocratic AI: $141 million to develop AI tools for clinical tasks.
- Qualified Health: $30 million for innovative AI solutions in healthcare.
- Collate: $30 million aimed at the pharmaceutical industry.
- Eli Lilly and Andreessen Horowitz announced a joint fund to invest $500 million in innovative technology, including AI developments.
Since the launch of OpenAI’s ChatGPT, interest in AI has surged, particularly in healthcare. According to Rock Health, AI startups accounted for 37% of digital health funding this year. While overall investments in health tech have decreased, AI-focused companies are still attracting significant funding.
This trend highlights the growing belief in AI’s potential to transform healthcare, making it an exciting area to watch in the coming months.
Source link
Artificial intelligence,health tech,Startups,STAT+,Venture capital